BACKGROUND: Infection by mosquito-borne flaviviruses (family Flaviviridae) is increasing in prevalence worldwide. The vast global, social and economic impact due to the morbidity and mortality associated with the diseases caused by these viruses necessitates therapeutic intervention. There is currently no effective clinical treatment for any flaviviral infection. Therefore, there is a great need for the identification of novel inhibitors to target the virus life cycle. DISCUSSION: In this article, we discuss structural and nonstructural viral proteins that are the focus of current target validation and drug discovery efforts. Both inhibition of essential enzymatic activities and disruption of necessary protein–protein interactions are considered. In addition, we address promising new targets for future research. CONCLUSION: As our molecular and biochemical understanding of the flavivirus life cycle increases, the number of targets for antiviral therapeutic discovery grows and the possibility for novel drug discovery continues to strengthen.
BACKGROUND:Infection by mosquito-borne flaviviruses (family Flaviviridae) is increasing in prevalence worldwide. The vast global, social and economic impact due to the morbidity and mortality associated with the diseases caused by these viruses necessitates therapeutic intervention. There is currently no effective clinical treatment for any flaviviral infection. Therefore, there is a great need for the identification of novel inhibitors to target the virus life cycle. DISCUSSION: In this article, we discuss structural and nonstructural viral proteins that are the focus of current target validation and drug discovery efforts. Both inhibition of essential enzymatic activities and disruption of necessary protein–protein interactions are considered. In addition, we address promising new targets for future research. CONCLUSION: As our molecular and biochemical understanding of the flavivirus life cycle increases, the number of targets for antiviral therapeutic discovery grows and the possibility for novel drug discovery continues to strengthen.
Authors: Suchetana Mukhopadhyay; Bong-Suk Kim; Paul R Chipman; Michael G Rossmann; Richard J Kuhn Journal: Science Date: 2003-10-10 Impact factor: 47.728
Authors: Eloise Mastrangelo; Mario Milani; Michela Bollati; Barbara Selisko; Frederic Peyrane; Vittorio Pandini; Graziella Sorrentino; Bruno Canard; Peter V Konarev; Dmitri I Svergun; Xavier de Lamballerie; Bruno Coutard; Alexander A Khromykh; Martino Bolognesi Journal: J Mol Biol Date: 2007-06-27 Impact factor: 5.469
Authors: Srikanth Venkatraman; Stéphane L Bogen; Ashok Arasappan; Frank Bennett; Kevin Chen; Edwin Jao; Yi-Tsung Liu; Raymond Lovey; Siska Hendrata; Yuhua Huang; Weidong Pan; Tejal Parekh; Patrick Pinto; Veljko Popov; Russel Pike; Sumei Ruan; Bama Santhanam; Bancha Vibulbhan; Wanli Wu; Weiying Yang; Jianshe Kong; Xiang Liang; Jesse Wong; Rong Liu; Nancy Butkiewicz; Robert Chase; Andrea Hart; Sony Agrawal; Paul Ingravallo; John Pichardo; Rong Kong; Bahige Baroudy; Bruce Malcolm; Zhuyan Guo; Andrew Prongay; Vincent Madison; Lisa Broske; Xiaoming Cui; Kuo-Chi Cheng; Yunsheng Hsieh; Jean-Marc Brisson; Danial Prelusky; Walter Korfmacher; Ronald White; Susan Bogdanowich-Knipp; Anastasia Pavlovsky; Prudence Bradley; Anil K Saksena; Ashit Ganguly; John Piwinski; Viyyoor Girijavallabhan; F George Njoroge Journal: J Med Chem Date: 2006-10-05 Impact factor: 7.446
Authors: Elena Pokidysheva; Ying Zhang; Anthony J Battisti; Carol M Bator-Kelly; Paul R Chipman; Chuan Xiao; G Glenn Gregorio; Wayne A Hendrickson; Richard J Kuhn; Michael G Rossmann Journal: Cell Date: 2006-02-10 Impact factor: 41.582
Authors: Paul A Johnston; Jennifer Phillips; Tong Ying Shun; Sunita Shinde; John S Lazo; Donna M Huryn; Michael C Myers; Boris I Ratnikov; Jeffrey W Smith; Ying Su; Russell Dahl; Nicholas D P Cosford; Sergey A Shiryaev; Alex Y Strongin Journal: Assay Drug Dev Technol Date: 2007-12 Impact factor: 1.738
Authors: Hillary J Stahla-Beek; Daniel G April; Bejan J Saeedi; Amanda M Hannah; Susan M Keenan; Brian J Geiss Journal: J Virol Date: 2012-06-06 Impact factor: 5.103
Authors: Brian J Geiss; Hillary J Stahla-Beek; Amanda M Hannah; Hamid H Gari; Brittney R Henderson; Bejan J Saeedi; Susan M Keenan Journal: J Biomol Screen Date: 2011-07-25